These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 23411968)

  • 41. [A case report of hepatic arterial infusion chemotherapy and RFA for liver metastasis from pancreatic cancer].
    Nakayama A; Tajima H; Kitagawa H; Shoji M; Nakanuma S; Makino I; Hayashi H; Nakagawara H; Miyashita T; Takamura H; Ohta T
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):2205-7. PubMed ID: 25731471
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Phase I trial of S-1 every other day in combination with gemcitabine/cisplatin for inoperable biliary tract cancer.
    Uwagawa T; Sakamoto T; Abe K; Okui N; Hata D; Shiba H; Futagawa Y; Aiba K; Yanaga K
    Cancer Chemother Pharmacol; 2015 Jan; 75(1):191-6. PubMed ID: 25422155
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [S-1+gemcitabine (GEM) therapy effective in a case of pancreatic body cancer with multiple liver metastasis].
    Fukui H; Kou C; Matsumoto T; Matsumoto M
    Gan To Kagaku Ryoho; 2010 Sep; 37(9):1775-8. PubMed ID: 20841945
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Phase I trial of oral S-1 combined with hepatic arterial infusion of gemcitabine in unresectable biliary tract cancer.
    Ishiwatari H; Hayashi T; Yoshida M; Ono M; Sato T; Miyanishi K; Sato Y; Takimoto R; Kobune M; Kato J
    Cancer Chemother Pharmacol; 2015 Apr; 75(4):805-12. PubMed ID: 25687990
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A multi-institution phase II study of gemcitabine/cisplatin/S-1 (GCS) combination chemotherapy for patients with advanced biliary tract cancer (KHBO 1002).
    Kanai M; Hatano E; Kobayashi S; Fujiwara Y; Marubashi S; Miyamoto A; Shiomi H; Kubo S; Ikuta S; Yanagimoto H; Terajima H; Ikoma H; Sakai D; Kodama Y; Seo S; Morita S; Ajiki T; Nagano H; Ioka T
    Cancer Chemother Pharmacol; 2015 Feb; 75(2):293-300. PubMed ID: 25477010
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Clinical benefit of full-dose gemcitabine for advanced pancreatic cancer refractory to S-1+gemcitabine].
    Hachisuka H; Takahashi M; Kushima A; Nakamoto T; Takahashi K; Iwamura Y; Wakata M; Nagano K; Nakajima T; Nunomura M; Araki K
    Gan To Kagaku Ryoho; 2013 May; 40(5):639-42. PubMed ID: 23863590
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Two Case Reports of Chemotherapy-Induced Radiation Myositis].
    Nishibuchi I; Wadasaki K
    Gan To Kagaku Ryoho; 2018 Jun; 45(6):1005-1007. PubMed ID: 30026433
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A phase I study of combination chemotherapy with gemcitabine and oral S-1 for advanced pancreatic cancer.
    Ueno H; Okusaka T; Ikeda M; Ishiguro Y; Morizane C; Matsubara J; Furuse J; Ishii H; Nagase M; Nakachi K
    Oncology; 2005; 69(5):421-7. PubMed ID: 16319514
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [A case of effective treatment with S-1/gemcitabine chemotherapy and resection for advanced pancreatic cancer with peritoneal dissemination].
    Koga H; Miyoshi A; Nakamura J; Ide T; Kitahara K; Noshiro H
    Gan To Kagaku Ryoho; 2014 May; 41(5):665-8. PubMed ID: 24917019
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Two cases of pancreatic cancer with multiple liver metastases treated with radical treatment after successful treatment with gemcitabine plus S-1 therapy].
    Sato Y; Tsuchiya Y; Aizawa M; Nomura T; Nashimoto A
    Gan To Kagaku Ryoho; 2014 Sep; 41(9):1151-4. PubMed ID: 25248901
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Gemcitabine-based versus fluoropyrimidine-based chemotherapy with or without platinum in unresectable biliary tract cancer: a retrospective study.
    Kim MJ; Oh DY; Lee SH; Kim DW; Im SA; Kim TY; Heo DS; Bang YJ
    BMC Cancer; 2008 Dec; 8():374. PubMed ID: 19091129
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A feasibility study of gemcitabine, S-1 and leucovorin combination therapy (GSL) for advanced biliary tract cancer.
    Takahara N; Isayama H; Nakai Y; Sasaki T; Saito K; Sato T; Hakuta R; Ishigaki K; Saito T; Hamada T; Mizuno S; Kogure H; Tada M; Koike K
    J Chemother; 2019 Sep; 31(5):284-289. PubMed ID: 31179889
    [No Abstract]   [Full Text] [Related]  

  • 53. [Curative resection of gallbladder cancer with simultaneous liver metastasis].
    Sanada T; Baba H; Baba H; Wakabayashi M; Nakamura H; Kuwabara H; Nakajima K; Goseki N
    Gan To Kagaku Ryoho; 2011 Nov; 38(12):2433-5. PubMed ID: 22202404
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [A long-term survival case of unresectable intrahepatic cholangiocarcinoma treated with chemotherapy].
    Tamura T; Mizuyama Y; Shinto O; Nishihara T; Nakagawa H; Ono Y
    Gan To Kagaku Ryoho; 2010 Nov; 37(12):2732-4. PubMed ID: 21224695
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [A case of recurrence after resection of stage IV advanced bile duct cancer responding well to S-1/cisplatin combination chemotherapy].
    Mori Y; Katsumata K; Tokita H; Kato F; Yamamoto J; Tsuchida A; Aoki T
    Gan To Kagaku Ryoho; 2007 Sep; 34(9):1485-7. PubMed ID: 17876152
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Phase I clinical trial of oral administration of S-1 in combination with intravenous gemcitabine and cisplatin in patients with advanced biliary tract cancer.
    Shoji H; Morizane C; Sakamoto Y; Kondo S; Ueno H; Takahashi H; Ohno I; Shimizu S; Mitsunaga S; Ikeda M; Okusaka T
    Jpn J Clin Oncol; 2016 Feb; 46(2):132-7. PubMed ID: 26685318
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A pilot study of concurrent chemoradiotherapy with gemcitabine and cisplatin in patients with locally advanced biliary tract cancer.
    Lee KJ; Yi SW; Cha J; Seong J; Bang S; Song SY; Kim HM; Park SW
    Cancer Chemother Pharmacol; 2016 Oct; 78(4):841-6. PubMed ID: 27586966
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A randomized phase II study of gemcitabine and S-1 combination therapy versus gemcitabine monotherapy for advanced biliary tract cancer.
    Sasaki T; Isayama H; Nakai Y; Ito Y; Yasuda I; Toda N; Kogure H; Hanada K; Maguchi H; Sasahira N; Kamada H; Mukai T; Okabe Y; Hasebe O; Maetani I; Koike K
    Cancer Chemother Pharmacol; 2013 Apr; 71(4):973-9. PubMed ID: 23355041
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of ω-3 Fatty Acid Supplementation in Patients with Bile Duct or Pancreatic Cancer Undergoing Chemotherapy.
    Abe K; Uwagawa T; Haruki K; Takano Y; Onda S; Sakamoto T; Gocho T; Yanaga K
    Anticancer Res; 2018 Apr; 38(4):2369-2375. PubMed ID: 29599363
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Multicenter, phase II study of gemcitabine and S-1 combination chemotherapy in patients with advanced biliary tract cancer.
    Sasaki T; Isayama H; Nakai Y; Ito Y; Kogure H; Togawa O; Toda N; Yasuda I; Hasebe O; Maetani I; Sasahira N; Hirano K; Tsujino T; Tada M; Omata M
    Cancer Chemother Pharmacol; 2010 May; 65(6):1101-7. PubMed ID: 19707761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.